Mesa Laboratories stock fell 4.12 percent to USD 122.48 on October 16, 2026

Published on 10/17/2026 at 19:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mesa Laboratories stock fell 4.12 percent to USD 122.48 on October 16, 2026. Q2 results are scheduled for November 5, 2026 after market close.

Price move and earnings date

Mesa Laboratories stock fell 4.12 percent on October 16, 2026.
First-quarter fiscal 2027 revenue reached USD 60.14 million, up 1.00 percent year over year.
Mesa Laboratories stock was last at USD 122.48 on October 16, 2026 at 4:00 p.m. ET.
Q2 fiscal 2027 results are scheduled for November 5, 2026 after market close.

MLAB, US59064R1095, Illustration mit AI erstellt.

Mesa Laboratories (ISIN US59064R1095) fell 4.12 percent to USD 122.48 on October 16, 2026, leaving the stock below its previous Nasdaq close of USD 127.74. The price was last quoted at 4:00 p.m. ET. MarketBeat lists November 5, 2026 as the estimated announcement date for Mesa Laboratories' second-quarter fiscal 2027 results.

Revenue reached USD 60.14 million

The latest reported period gives the earnings date a concrete operating backdrop. In the first quarter of fiscal 2027, revenue reached USD 60.14 million, up 1.00 percent year over year, while earnings per share came to USD 2.68. MarketBeat identifies those figures as the latest reported quarter.

Price sits below the yearly high

The Nasdaq price stood within a USD 69.51 to USD 144.35 52-week range on October 16, 2026. At USD 122.48, the stock was 15.18 percent below its yearly high. Trading volume was 74,350 shares against an average of 134,742, while the same-day decline was 4.12 percent.

Valuation and November results

Mesa Laboratories had a market capitalization of USD 685.4 million and a P/E ratio of 145.81 on October 16, 2026. The next scheduled event is the second-quarter fiscal 2027 earnings announcement on November 5, 2026 after market close. The following conference call is scheduled for November 9, 2026 at 4:00 p.m. ET, according to MarketBeat.

Comparison with peers

Mesa Laboratories (Nasdaq, USD): minus 4.12 percent, P/E 145.81, market capitalization USD 685.4 million
Becton, Dickinson and Company (NYSE, USD): minus 1.04 percent, P/E 57.76, market capitalization USD 52.2 billion
Thermo Fisher Scientific (NYSE, USD): minus 0.93 percent, P/E 37.12, market capitalization USD 255.1 billion

Nasdaq price after the decline

Mesa Laboratories' 52-week high of USD 144.35 leaves the stock 15.18 percent above its last quoted price of USD 122.48 on October 16, 2026. The lower volume and elevated P/E ratio frame the November earnings date as the next scheduled company event.